Wei-Mi-Shu, a Stomach-Harmonizing Herbal Prescription, Alleviates Chronic Gastritis with Liver‑Stomach Disharmony by Modulating IL-6/STAT3 Signaling
Journal of Inflammation Research · 2026-01 · Volume 19 · 1-16
DOI: 10.2147/jir.s556234 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Inflammation Research, 2026-01. Verfasst von Xiaoyun Zou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatopathy, Qinghai Provincial Hospital of Traditional Chinese Medicine, Xining, 810000, People's Republic of China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Objective
Chronic gastritis, with the liver-stomach disharmony (CG-LSD) type being particularly common, is a prevalent digestive disorder. The Chinese herbal prescription "Wei-Mi-Shu (WMSP)" demonstrated positive therapeutic outcomes in clinical practice for CG-LSD. This study aimed to verify the therapeutic effect of WMSP on CG-LSD and reveal its molecular mechanism based on IL-6/STAT3 pathway.
Methods
Network pharmacology analysis was employed to predict the target genes of WMSP for CG. Following this, a CG-LSD rat model was treated with WMSP, and the changes in body weight, syndrome score, and motor ability were analyzed. The gastric mucosal damage was examined by HE, AB-PAS, and scanning electron microscopy. Serum levels of inflammatory factors and mucosal injury factors were measured via ELISA. Apoptosis was evaluated by TUNEL staining, and the protein expression related to apoptosis and the IL-6/STAT3 pathway was determined by WB. Additionally, a Helicobacter pylori (H. pylori)-infected GES-1 cell model was established to measure cell activity, inflammatory factors levels, and IL-6/STAT3 pathway activation.
Results
Network pharmacology identified 674 common targets between WMSP and CG, including key genes such as TP53, AKT1, TNF, IL-6, and STAT3. In CG-LSD rat models, WMSP significantly improved general health (body weight, symptoms, motor ability), suppressed serum inflammatory factors, and ameliorated gastric mucosal damage (P
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hepatopathy, Qinghai Provincial Hospital of Traditional Chinese Medicine, Xining, 810000, People's Republic of China.
- Department of Cardiology, Qinghai Provincial Hospital of Traditional Chinese Medicine, Xining, 810000, People's Republic of China.
- Department of Research Institute of Traditional Chinese Medicine, Qinghai Provincial Hospital of Traditional Chinese Medicine, Xining, 810000, People's Republic of China.
- Department of Pharmacy, Qinghai Provincial Hospital of Traditional Chinese Medicine, Xining, 810000, People's Republic of China.
- Medical College, Qinghai University, Xining, 810016, People's Republic of China.
- Department of Spleen and Stomach Diseases, Qinghai Provincial Hospital of Traditional Chinese Medicine, Xining, 810000, People's Republic of China.
ORCID-Profile: Yan Liu
Zitieren
APA
Zou, X., Wei, M., Jia, S., Qi, Y., Li, H., Liu, Y., & Li, J. (2026). Wei-Mi-Shu, a Stomach-Harmonizing Herbal Prescription, Alleviates Chronic Gastritis with Liver‑Stomach Disharmony by Modulating IL-6/STAT3 Signaling. Journal of Inflammation Research, Volume 19, 1-16. https://doi.org/10.2147/jir.s556234
Vancouver
Zou X, Wei M, Jia S, Qi Y, Li H, Liu Y, et al. Wei-Mi-Shu, a Stomach-Harmonizing Herbal Prescription, Alleviates Chronic Gastritis with Liver‑Stomach Disharmony by Modulating IL-6/STAT3 Signaling. Journal of Inflammation Research. 2026;Volume 19:1-16. doi:10.2147/jir.s556234
BibTeX
@article{Zou2026,
author = {Zou, Xiaoyun and Wei, Minmin and Jia, Shouning and Qi, Yongfu and Li, Hailing and Liu, Yan and Li, Junru},
title = {Wei-Mi-Shu, a Stomach-Harmonizing Herbal Prescription, Alleviates Chronic Gastritis with Liver‑Stomach Disharmony by Modulating IL-6/STAT3 Signaling},
journal = {Journal of Inflammation Research},
year = {2026},
volume = {Volume 19},
pages = {1--16},
doi = {10.2147/jir.s556234}
}
EUVIMED